# BENLYSTA® Special Drug Use Investigation

> **NCT03370263** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1514 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Benlysta

## Key facts

- **NCT ID:** NCT03370263
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 1514 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370263, "BENLYSTA® Special Drug Use Investigation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03370263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*